Jeffrey LaRose, Chief Scientific Officer at HeartWare International, Inc. (HTWR), sold 491 shares at $86.46 ($42K) on 2015-02-09, disclosed to the SEC on 2015-02-10.
Scheduled sale ($42k) by Chief Scientific Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HTWR | SELL | 2016-02-09 | $20K | — | Filing → |
| HTWR | SELL | 2015-12-23 | $57K | — | Filing → |
| HTWR | SELL | 2015-02-26 | $30K | — | Filing → |